Improving quality of life for patients with hyperventilation syndrome through respiratory rehabilitation
Impact of Respiratory Rehabilitation on Quality of Life, Measures by the SF-36 Score, in Patients With Hyperventilation Syndrome: Crossover, Prospective and Randomized Study
This study tests whether a special breathing therapy can help people with hyperventilation syndrome feel better and improve their daily lives.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Régional d'Orléans Academic / other |
| Locations | 1 site (Orléans) |
| Trial ID | NCT04668638 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of respiratory rehabilitation on the quality of life for patients diagnosed with hyperventilation syndrome, a condition that significantly impacts daily living. Given the lack of effective medicinal treatments, the study focuses on physiotherapy as a potential intervention to alleviate symptoms and improve overall well-being. Participants will undergo a structured rehabilitation program, and their progress will be assessed to determine the effectiveness of this approach. The study aims to fill the gap in literature regarding the benefits of physiotherapy for this condition.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have a confirmed diagnosis of hyperventilation syndrome and are able to provide informed consent.
Not a fit: Patients with chronic and degenerative pathologies or those who have recently undergone respiratory rehabilitation may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a non-pharmacological treatment option that significantly enhances the quality of life for patients suffering from hyperventilation syndrome.
How similar studies have performed: While there is limited literature on the specific impact of physiotherapy for hyperventilation syndrome, other studies have shown positive outcomes for similar rehabilitation approaches in respiratory conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Positive hyperventilation syndrome diagnosis * Having a social security insurance * Being at least 18 years old * Having given their written consent Exclusion Criteria: * Being put under guardianship or curatorship * Having seen a physiotherapist for a respiratory rehabilitation in the last three months * Suffering from a chronic and degenerative pathology (chronic obstructive pulmonary disease, Parkinson's disease, idiopathic fibrosis, ...) * Not being able to receive the respiratory rehabilitation from our care providers * Already having received a rehabilitation for hyperventilation syndrome * Not speaking French or not being unable to complete the questionnaires
Where this trial is running
Orléans
- CHR d'Orléans — Orléans, France (Recruiting)
Study contacts
- Principal investigator: Louis-François BIRNESSER — CHR Orléans
- Study coordinator: Aurélie DESPUJOLS
- Email: aurelie.despujols@chr-orleans.fr
- Phone: +33238744071
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.